HSDT实时信号 | 通过Getagraph.com最大化利润

购买 116422 min ago

@ $6.10

发出时间: 9 Feb 2024 @ 03:18

回报率: -31.99%

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 23:37):

Stats
今日成交量	23 790.00
平均成交量	412 233
市值	3.68M
EPS	$0 ( 2024-03-28 )
下一个收益日期	( $-2.70 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.290
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-01	Andreeff Dane	Buy	643	Common Stock
2023-11-30	Andreeff Dane	Buy	641	Common Stock
2023-12-14	Andreeff Dane	Buy	2 827	Common Stock
2023-12-14	Andreeff Dane	Buy	1 603	Common Stock
2023-12-14	Andreeff Dane	Buy	570	Common Stock

INSIDER POWER
100.00
Last 99 transactions
Buy: 12 106 108 \| Sell: 0

Helius Medical 相关性

10 最正相关
PASG	0.818
BPRN	0.81

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Helius Medical 财务报表

Annual	2023
营收:	$644 000
毛利润:	$-101 000 (-15.68 %)
EPS:	$-14.56

FY	2023
营收:	$644 000
毛利润:	$-101 000 (-15.68 %)
EPS:	$-14.56

FY	2022
营收:	$787 000
毛利润:	$324 000 (41.17 %)
EPS:	$-46.52

FY	2021
营收:	$522 000
毛利润:	$224 000 (42.91 %)
EPS:	$-0.433

Financial Reports:

No articles found.

Helius Medical

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.